glp-1 faa glp-1_analogs [TUSOM The FAA has approved certain

Mechanism Although the biological rationale for GLP-1 RA-induced biliary toxicity is not clear, the current findings indicate potential weight-loss-dependent mechanisms

FDA , FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize (Feb 2025) ( [62] )

To address this limitation, various long-acting GLP-1 analogues have been developed, designed to prolong in vivo efficacy and enhance therapeutic potential (Table 1)

Existing mental health treatment should be optimized and stable before starting weight loss medication, and psychiatric providers should be informed about the new prescription to coordinate care effectively

The manufacturers in animal studies have said that there could be adverse outcomes